17
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Relation Between Hypercalciuria and Vitamin D3-Status in Patients with Urolithiasis

, , , &
Pages 269-273 | Received 16 May 1981, Published online: 15 Feb 2010

REFERENCES

  • Albright, F., Henneman, P., Benedict, P. H. & Forbes, A. D. 1953. Idiopathic hypercalciuria. Proc R Soc Med 46, 1077.
  • Björkhem, I. & Holmberg, I. 1978a. Assay and properties of a mitochondrial 25-hydroxylase active on vitamin D3. J Biol Chem 253, 842.
  • Björkhem, I. & Holmberg, I. 1978b. Mass fragmentography of 25-hydroxy vitamin D3. In: Quantitative mass spectrometry. Life Sciences, ii, pp. 167–74. Elsevier, Amsterdam.
  • Björkhem, I. & Holmberg, I. 1980. Mass fragmentographic assay of 25-hydroxy vitamin D3. Methods of Enzymology 67, 385.
  • Bordier, P., Ryckward, A., Gueris, J. & Rasmussen, H. 1977. On the pathogenesis of the so-called idiopathic hypercalciuria. Amer J Med 63, 398.
  • Caldas, A. E., Gray, R. W. & Lemann, J. 1978. The simultaneous measurement of vitamin D metabolites in plasma: studies in healthy adults and in patients with calcium nephrolithiasis. J Lab Clin Med 91, 840.
  • Coe, F. C. & Kavalach, A. G. 1974. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 25, 1344.
  • DeLuca, H. F. 1979. Vitamin D, metabolism and function. Monographs on Endocrinology. Springer Verlag, New York.
  • Gray, R. W., Wilz, D. R., Caldas, A. E. & Lemann, J. 1977. The importance of phosphate in regulating plasma 1,25-dihydroxy vitamin D levels in human: studies in healthy subjects, in calcium stone formers, and in patients with primary hyperparathyroidism. J Clin Endocrin Metab 45, 299.
  • McLaughlin, M., Fairney, A., Lester, E., Raggatt, P. R., Brown, D. J. & Wills, M. R. 1974. Seasonal variations in serum 25-hydroxycholecalciferol in healthy people. Lancet 1, 536.
  • Pak, C. Y. 1979. Physiological basis of absorptive and renal hypercalciurias. Am J Physiol 237, F415.
  • Parry, H. S. & Lister, I. S. 1975. Sunlight and hypercalciuria. Lancet, i, 1063.
  • Procsal, D. A., Okamura, W. H. & Norman, A. W. 1975. Structural requirements for the interaction of 1,25-dihydroxy vitamin D3 with its chick intestinal receptor system. J Biol Chem 250, 8382.
  • Reeve, J. 1979. Therapeutic application of vitamin D analogues. Br Med J 2, 888.
  • Rose, G. A. & Harrison, A. R. 1974. The incidence, investigation and treatment of idiopathic hypercalciuria. Br J Urol 46, 261.
  • Robertson, W. G., Gallagher, J. C., Marshall, D. H., Peacock, M. & Nordin, B. E. C. 1974. Seasonal variations in urinary excretion of calcium. Br Med J 4, 436.
  • Schmidt-Gayk, H., Tschöpe, W., Schellenberg, B., Schlierf, G. & Walch, S. 1979. Vitamin D-Stoffwechsel bei Urolithiasis: Neuere Befunde und Untersuchungsmetoden. Therapiewoche 29, 2137.
  • Scholz, D., Schwille, P. O., Ulbrich, D., Bausch, W. M. & Sigel, A. 1979. Composition of renal stones and their frequency in a stone clinic: Relationship to parameters of mineral metabolism in serum and urine. Urol Res 7, 161.
  • Shen, F. H., Baylink, D. J., Nielsen, R. L., Sherrard, D. J., Ivey, J. L. & Haussler, M. R. 1977. Increased serum 1,25-dihydroxy vitamin D3 in idiopathic hypercalciuria. J Lab Clin Med 90, 955.
  • Transbøl, I., Schønau-Jørgensen, F., Lund, B. & Sørensen, O. H. 1976. Importance of season and clearance correction in the definition of hypercalciuria. Acta Med Scand 199, 127.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.